Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes.
Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes. — المؤلف: Kanamori, Takehiro — BMJ open diabetes research & care 2018
- المؤلف
- Kanamori, Takehiro
- النشر
- BMJ open diabetes research & care 2018
- الوصف
- e000588 p.